文献速递脊柱关节炎

强直性脊柱炎患者一级亲属的慢性背痛:HLA-B27预测价值与炎性背痛持续性

Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time.
PubMed 文献 · RMD Open · 2020-01-01

该研究纳入399例强直性脊柱炎(AS)患者的一级亲属(FDRs),分为无慢性背痛(CBP)、非炎性CBP和炎性CBP三组,并与NHANES 2009-2010中772例CBP患者比较。结果显示炎性CBP在FDRs中与HLA-B27相关(57% vs 39.6%,p=0.005,OR=1.9),起病更早且更易持续(73% vs 31%)。

要点

  • AS患者FDRs中炎性CBP与HLA-B27显著相关(OR=1.9)。
  • 炎性CBP较非炎性CBP起病更早且足跟痛更常见。
  • 炎性CBP在随访中倾向于持续存在。

核心结论

  • AS患者FDRs的炎性CBP与HLA-B27相关,起病更早且较非炎性CBP更易持续。

研究设计与样本

  • 399例AS先证者FDRs分为无CBP(n=162)、非炎性CBP(n=82)和炎性CBP(n=155)三组。
  • 白人CBP的FDRs与NHANES 2009-2010中772例CBP参与者进行比较。
  • FDRs被邀请返回进行再评估。

主要发现

  • 炎性CBP的FDRs较非炎性CBP者CBP起病更早(p<0.001)。
  • 炎性CBP者较无CBP者足跟痛频率更高(p=0.002)。
  • HLA-B27在炎性CBP者中占57%,无CBP者中占39.6%(p=0.005,OR=1.9)。
  • 基线炎性CBP者23例在67.04±31.02个月后复评,16例(73%)仍有炎性CBP。
  • 基线非炎性CBP者13例在61.23±31.84个月后复评,4例(31%)仍有症状。

关键数值与推荐

  • HLA-B27在炎性CBP的FDRs中频率为57%,在无CBP的FDRs中为39.6%(p=0.005,OR=1.9)。
  • 炎性CBP者随访67.04±31.02个月后73%持续有炎性CBP;非炎性CBP者随访61.23±31.84个月后31%仍有症状。

临床怎么用

  • 对AS患者FDRs出现慢性背痛者应评估是否为炎性CBP并考虑检测HLA-B27。
  • 炎性CBP的FDRs需长期随访,因其症状持续比例较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/PURPOSE: First-degree relatives (FDRs) of patients with ankylosing spondylitis (AS) may be at high risk of spondyloarthritis. We examined the frequency, characteristics of chronic back pain (CBP), associated features, persistence of symptoms, and HLA-B27 allele frequency in FDRs of AS patients, also comparing those FDRs with participants in NHANES 2009-2010 with CBP. METHODS: 399 FDRs of AS probands were divided into: (1) No CBP (subjects >40 years old at study visit without CBP) (n=162); (2) NICBP (non-inflammatory CBP) (n=82), and (3) CIBP (inflammatory CBP) (n=155). White FDRs with CBP were compared with 772 participants in NHANES 2009-2010 with CBP. FDRs were invited to return for reassessment. RESULTS: FDRs with CIBP had earlier onset of CBP than those with NICBP (p<0.001) and had higher frequency of heel pain than those without CBP (p=0.002). HLA-B27 occurred in 57% of FDRs with CIBP vs 39.6% of those without CBP (p=0.005, OR=1.9). Of 23 patients with CIBP at baseline re-evaluated 67.04±31.02 months later, 16 (73%) still had CIBP, whereas 4 (31%) of 13 NICBP patients seen 61.23±31.84 months later remained symptomatic. CONCLUSION: CIBP in FDRs of AS patients is HLA-B27-associated, has earlier onset and tends to persist compared to NICBP.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Doughem K, Weisman MH, Ward MM, et al. Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time. RMD Open. 2020. PMID: 33243782. doi:10.1136/rmdopen-2020-001418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。